France· FR:69548508
STIVARGA 40 mg, comprimé pelliculé
A medicinal product containing régorafénib monohydraté, registered in France by BAYER AG (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- RÉGORAFÉNIB MONOHYDRATÉ
- Manufacturer
- BAYER AG (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009275200063 flacon(s) polyéthylène haute densité (PEHD) de 28 comprimé(s)EUR 2.15
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Régorafénib monohydraté in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandStivargaBayer AG
- CzechiaSTIVARGABayer AG, Leverkusen
- SpainSTIVARGA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULABayer Ag
- IrelandStivarga 40 mg film-coated tabletsBayer Pharma AG
- IcelandStivargaBayer AG*
- NetherlandsStivarga 40 mg, filmomhulde tabletBayer AG
- NorwayStivargaBayer AG
- PolandStivargaBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Stivarga
- Liechtenstein · Stivarga
- Norway · Stivarga
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab8a6aec-fbc8-4f4f-8fa2-3244e5e7b4d1 GET /v1/drugs/ab8a6aec-fbc8-4f4f-8fa2-3244e5e7b4d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69548508",
"date_amm": "2013-08-26",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/13/858",
"substance": "RÉGORAFÉNIB MONOHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about régorafénib monohydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.